American Green (American Green) Capex-to-Revenue : 0.07 (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is American Green Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

American Green's Capital Expenditure for the six months ended in Jun. 2023 was $-0.26 Mil. Its Revenue for the six months ended in Jun. 2023 was $3.79 Mil.

Hence, American Green's Capex-to-Revenue for the six months ended in Jun. 2023 was 0.07.

American Green Capex-to-Revenue Historical Data

The historical data trend for American Green's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Green Capex-to-Revenue Chart

American Green Annual Data

Trend

Jun22

Jun23

Capex-to-Revenue

2.63

0.07

American Green Semi-Annual Data
	Jun22	Jun23
Capex-to-Revenue	2.63	0.07

Competitive Comparison of American Green's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, American Green's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

American Green's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, American Green's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where American Green's Capex-to-Revenue falls into.

American Green Capex-to-Revenue Calculation

American Green's Capex-to-Revenue for the fiscal year that ended in Jun. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-0.261)	/	3.793
	=	0.07

American Green's Capex-to-Revenue for the quarter that ended in Jun. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-0.261)	/	3.793
	=	0.07

American Green (OTCPK:ERBB) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

American Green Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of American Green's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

American Green (American Green) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » American Green Inc (OTCPK:ERBB) » Definitions » Capex-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

30 N Gould Street, Suite R, Sheridan, WY, USA, 82801

Website

https://www.americangreen.com

American Green Inc is a technology company in the medical cannabis industry. It is involved in the business of developing a cultivation facility in Phoenix Arizona for medical marijuana and also owns proprietary dispensing machines and all rights to a line of health supplements.